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Abstract Contamination of retrieved tissues is a
major problem for allograft safety. Consequently,
tissue banks have implemented decontamination pro-
tocols to eliminate microorganisms from tissues.
Despite the widespread adoption of these protocols,
few comprehensive studies validating such methods
have been published. In this manuscript we compare
the bactericidal activity of different antibiotic cock-
tails at different temperatures against a panel of
bacterial species frequently isolated in allograft tissues
collected at the Treviso Tissue Bank Foundation, a
reference organization of the Veneto Region in Italy
that was instituted to select, recover, process, store and
distribute human tissues. We were able to identify at
least two different formulations capable of killing
most of the bacteria during prolonged incubation at
4 C.
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Introduction
Microbiological contamination of retrieved tissues is a
very important topic and a critical aspect of allograft
safety, especially when dealing with multi-tissue
donors. Tissues retrieved from cadavers and living
donors are frequently contaminated as a consequence
of the retrieval and handling process, as well as the
donor’s inherent bio-burden. Contaminated tissues
may represent a potential hazard to recipients, and
may only be implanted in the new host when proven to
be efficiently decontaminated (Gottesdiener 1989;
Eastlund 2006). The spectrum and frequency of
bacterial contamination in tissues is very heteroge-
neous, mainly depending on tissue and donor type.
Heart valves are usually more contaminated than
musculoskeletal tissues (Ireland and Spelman 2005).
In addition, it is well known that commensal bacteria
(e.g. Staphylococci) and enteric bacteria are the most
prevalent isolated organisms (van Kats et al. 2010).
Despite measures to minimize contamination, such as
the reduction of cadaver time (the time elapsed
between death and start of retrieval) and the number
of persons attending the retrieval, there is always a risk
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of bacterial contamination. Consequently, decontam-
ination is a critical aspect, and tissue banks worldwide
have established a wide variety of protocols to
eliminate bacteria and fungi from isolated tissues
(Steffen et al. 2015; Jashari et al. 2007; Heng et al.
2013). The common decontamination procedure usu-
ally includes a treatment with an antibiotic cocktail at
4 C (Germain et al. 2010); however, the decontam-
ination methods used in 17 European cardiovascular
tissue banks were recently found to have large
methodological differences (composition of cocktails,
time and temperature of treatment), suggesting the
need to validate and standardize the procedures (De
By et al. 2012).
The aim of this study is to identify a new cocktail
more efficient at low temperatures than the one
currently used at Treviso Tissue Bank Foundation
(FBTV), a reference organization of the Veneto Region
in Italy instituted for the purpose of selecting, recover-
ing, processing, storing and distributing musculoskele-
tal and cardiovascular tissues and amniotic membranes.
Recently, Pitt et al. (2014) compared the activity of
different antibiotic cocktails used in tissue banks in the
United Kingdom at different temperatures against
bacteria commonly isolated from contaminated tis-
sues. As expected, the efficacy of the cocktails
increased with temperature; however, cocktails con-
taining ciprofloxacin, gentamicin and imipenem were
those whose efficacy was less affected by temperature
with a good efficacy also at 4 C, the temperature of
choice to decontaminate allografts. Since the cocktail
currently in use at FBTV does not include any of these
drugs, we hypothesised that we could increase decon-
tamination efficacy using a new cocktail including
them. Based on this hypothesis, we formulated and
tested new antibiotic combinations including cipro-
floxacin, gentamicin and imipenem, against a panel of
bacterial species frequently isolated in tissues col-
lected by FBTV, comparing their activity with that of
the cocktail currently in use.
Methods
Identification of bacteria contaminating allograft
tissues
Following collection from living or cadaveric donors,
tissues were decontaminated twice: initially upon
retrieval and subsequently after processing. Each
decontamination step entailed incubation for 24–48 h
at 4 C in RPMI containing ceftazidime 240 lg/ml
(Fresenius-Kabi), lincomycin 120 lg/ml, polymyxin B
100 lg/ml (Biochrom) and vancomycin 50 lg/ml
(Hospira). Samples for microbiological analyses were
collected upon retrieval and after each decontamination
step. Samples were cultivated using BD BACTEC
Fluorescent Test Technology (BM BACTECTM plus
aerobic/F and anaerobic/F culture vials); Soybean-
casein digest broth was used in a qualitative procedure
for aerobic/anaerobic culture and recovery of bacteria
and yeast. If positive, bacteria were isolated and
identified using standard procedures.
Bacterial strains, standard media and growth
condition
Table 1 shows the 34 strains belonging to 28 bacterial
species used in this study and their source. The strains
were routinely grown at 37 C in a controlled atmo-
sphere (Tab. S1) in Blood agar, Chocolate agar
(Haemophylus and Granulicatella genus) or MacCon-
ckey (Proteus, in order to avoid swarming motility).
Minimal inhibitory concentration (MIC) and minimal
bactericidal concentration (MBC) estimations were
performed in standard media used in clinical practice:
Mueller–Hinton II Broth Cation adjusted (Ther-
mofisher) supplemented with 2–5 % horse lysed blood
when needed (Streptococcus, Corynebacterium and
Gemella genera), Brucella Broth (Thermofisher) sup-
plemented with 10 mg/l vitamin K, 5 mg/l hemin and
5 % horse lysed blood (anaerobes and Granulicatella
genera). Antibiotic stock solutions for polymyxin B
(Biochrom), meropenem (Fresenius Kabi Italia), cef-
tazidime (Teva) and vancomycin (Normon) were
prepared in water and stored at -80 C in 30–40 ll
aliquots. For the other drugs, we used commercially
available ready-to-use injectable solutions: ciproflox-
acin (Ciproxin 2 mg/ml, Fresenius Kabi Italia), gen-
tamicin sulphate (40 mg/ml, Fisiopharma) and
lincomycin (300 mg/ml Pfizer).
Antimicrobial susceptibility
A 0.5 McFarland bacterial suspension (107–108 cells/
ml) was diluted 1:100 in 11 ml of Mueller–Hinton II
broth and aliquoted in a transparent 96-well plate
(100 ll/well = 104–105 cells/well). In the first well,
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100 ll of 29 antibiotic solution were added and then
1:2 scalar dilutions were performed. The final antibi-
otic concentration/well for each antibiotic is indicated
in Table S2. As a consequence of the 1:2 dilutions, the
final amount of cells was reduced to 103–104 cells/
well. The 96-well plates were incubated at 37 C until
the appearance of a ‘‘pellet’’ at the bottom or
cloudiness in the control well (without antibiotic).
The minimum concentration able to inhibit growth (no
pellet or cloudiness) was recorded as the MIC.
Samples from the first three wells with no growth
were spread on solid medium plates and incubated at
37 C for 24–96 h (depending on the genus) to
evaluate the MBC.
Antibiotic cocktail formulations
The FBTV foundation currently uses a combination of
4 antibiotics, indicated in Table 2 as cocktail Z.
Recently, Pitt et al. (2014) on behalf of National
Table 1 List of the strains






Bacterial species Strain name Source
Achromobacter xilosoxidans denitrificans CIP 77.15T PC
Acinetobacter baumannii AS1 MVP
Aerococcus viridans AS2 MVP
Aeromonas hydrophyla AS3 MVP
Bacteroides fragilis AS4 MVP
Corynebacterium striatum AS5 MVP
Enterococcus faecalis ATCC29212 ATCC
Enterococcus faecalis ATCC51299 ATCC
Escherichia coli ATCC25922 ATCC
Gemella morbillorum CIP 81.10T PC
Granulicatella adiacens AS6 MVP
Haemophilus parainfluenzae AS7 MVP
Klebsiella pneumoniae ATCC700603 ATCC
Klebsiella pneumoniae ATCC1706 ATCC
Kocuria kristinae CIP 81.69T PC
Lactobacillus salivarius AS7 MVP
Leuconostoc mesenteroides mesenteroides CIP 102388 PC
Micrococcus luteus AS8 MVP
Moraxella osloensis CIP 100025 PC
Peptostreptococcus anaerobius CIP 104411T PC
Propionibacterium acnes AS9 MVP
Proteus mirabilis AS10 MVP
Proteus mirabilis AS11 MVP
Staphylococcus aureus AS12 (MRSA) MVP
Staphylococcus aureus ATCC2913 (MSSA) ATTC
Staphylococcus epidermidis AS13 MVP
Staphylococcus epidermidis AS14 MVP
Staphylococcus hominis AS15 MVP
Staphylococcus hominis AS16 MVP
Staphylococcus hominis AS17 MVP
Sphingomonas paucimobilis CIP 100752T PC
Streptococcus agalactiae AS18 MVP
Streptococcus mitis AS19 MVP
Streptococcus salivarius AS20 MVP
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Health Service Blood and Transplant (NHSBT) com-
pared bactericidal activity of several antibacterial and
anti-fungal drugs combinations in bacterial and fungal
strains commonly contaminating allograft tissues
(some of which expressed significant levels of antibi-
otic resistance) at 4, 22 and at 37 C. In this study, the
cocktails with the highest efficacy at 4 C were those
ones containing gentamicin, vancomycin and imipe-
nem or ciprofloxacin. On the basis of their data, we
formulated 4 new cocktails (named A, B, C and D)
containing different combinations of the antibiotics
used by Pitt et al., but excluding the anti-fungal drugs
(Table 2). Moreover, we replaced imipenem with
meropenem due to its better availability and lower
cost. We performed an initial preliminary screening
test to evaluate the bactericidal activity of the test
cocktails on 4 of the 34 selected bacterial strains (two
Gram-positive and two Gram-negative strains with
different MBC levels: Escherichia coli, Proteus
mirabilis AS10, Staphylococcus aureus MSSA and
Staphylococcus hominis AS15). The assay was per-
formed by incubating bacteria in the cocktail for 24 or
48 h at 4 C. Based on this preliminary experiment,
we observed that cocktails A and B had lower activity
than the others against Staphylococcus strains, and
were therefore excluded from further analysis.
Cocktail evaluation
A 0.5 McFarland bacterial suspension (107–108 cells/
ml) was diluted 1:100 (105–106 cells/ml) in 2.5 ml of
BASE medium (Alchimia) to which 0.5 % of fetal calf
serum and the different antibiotic cocktails were
added. Samples were incubated at 22 or 4 C without
shaking. The number of CFU/ml was determined at
different time points after adding the cocktail (T0,
T6 h for samples incubated at 22 C and T0, T24 h
and T48 h for samples incubated at 4 C). Viable
counts (CFU/ml) were determined by plating 1:10
scalar dilutions of the bacterial suspension on solid
media and counting the resulting colonies after
incubation in the proper conditions. To avoid antibi-
otic carry-over, bacteria were pelleted at 10,000g for
50 at 4 C and suspended in the same volume of fresh
medium before dilution. The bactericidal activity was
calculated as:
fðCFU=ml after treatmentÞ=ðCFU=ml before treatment)g
 100
Results
Bacterial species isolated from allograft tissues
after decontamination
To select a panel of bacterial strains representing those
currently contaminating tissues, we conducted a
survey in 2012 and 2013 to isolate and identify all
contaminating bacteria found in allografts at FBTV
following the protocol actually used at FBTV reported
in the Methods section. We singled out 102 bacterial
species belonging to 47 genera (Tab. S3). Non-
compliers species, according to FBTV policy
(Clostridium spp., Fungi/yeasts, Mycobacterium
spp., Streptococcus pyogenes, Streptococcus pneumo-
niae, Pseudomonas aeruginosa, Serratia marcescens
and Meningococcus spp.), were excluded from the list.
Species isolated in at least three different tissues (27
species belonging to 23 different genera), were
selected for this study. For frequently detected species
we decided to analyse more than one strain, making a
total of 34 strains (Table 1).
Assessment of antibiotic MBCs
To obtain a theoretical indication of the efficacy of the
cocktails, we evaluated the MIC and MBC of each
antibiotic for all strains (Table 3). Comparing the
MBCs of the various strains, we made the following
overall observations: (a) meropenem is the antibiotic
with the greatest bactericidal effect, showing an MBC
B1 lg/ml on 65 % of the strains, followed by
ciprofloxacin with an MBC B2 lg/ml on 62 % of
the strains; (b) meropenem and ciprofloxacin have a
Table 2 Antibiotic cocktails used in this study
Antibiotic Antibiotic cocktail (lg/ml)
Z A B C D
Ciprofloxacin – 200 200 – 200
Ceftazidime 240 – – – –
Gentamicin – 200 – 200 200
Lyncomicin 120 – – – –
Meropenem – 200 200 200 –
Polymyxin B 100 – – –
Vancomycin 50 100 100 100 100
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broad spectrum of action; (c) polymyxin B, cef-
tazidime and lincomycin showed the lowest bacteri-
cidal effect on most of the strains analysed, killing just
35, 53 and 39 % of the strains respectively, at a
concentration of B8 lg/ml; (d) gentamicin resulted to
be the best antibiotic or one the best for particularly
low susceptible strains as Klebsiella pneumoniae
ATCC1706, Leuconostoc mesenteroides and Entere-
coccus faecalis ATCC29212.
Efficacy of antibiotic cocktails at 4 C
The efficacy of cocktails C and D at 4 C was
compared with that of the cocktail currently used at
FBTV (cocktail Z). Figure 1 reports the bactericidal
activity of cocktails Z, C and D for each strain, and
clearly shows that the bactericidal activity of cocktails
C and D was higher than that of cocktail Z on several
bacterial strains, in particular against those belonging
to Streptococcus and Staphylococcus genera. As
expected, the activity increased with the extension of
the treatment to 48 h (Figs. 1, 2). In particular, 21 out
of 34 (61 %) and 23 out of 34 (67 %) total strains
showed a kill rate higher than 95 % when incubated
with cocktail C or D, respectively, compared to only
15 out of 34 (44 %) total strains for cocktail Z
(Fig. 3a).
Efficacy of antibiotic cocktails at 22 C
To evaluate the possibility of treating tissues at higher
temperatures but for shorter periods, we tested the
efficacy of these cocktails at 22 C for 6 h. As
expected, under such conditions the bactericidal
activity of the cocktails was higher than at 4 C,
exceeding 95 % in most strains (Fig. 4). Again,
cocktails C and D showed greater bactericidal activity:
28 out of 34 (82 %) and 29 out of 34 (85 %) total
strains showed a kill rate higher than 95 % when
incubated with cocktail C or D, respectively, com-
pared to only 21 out of 34 (62 %) for cocktail Z
(Fig. 3b).
Discussion
Tissue decontamination is a challenge for tissue banks.
However, the standardization and validation of speci-
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cocktails have rarely been pursued, consequently a
wide range of antibiotic formulations, temperatures
and exposure times are currently adopted for this
purpose (Heng et al. 2013; De By et al. 2012; Germain
et al. 2010).
Taking the assessments reported by Pitt et al.
(2014), on the efficacy of different antibiotic cocktails
at 4 and 22 C against a wide panel of bacterial strains,
we designed 4 different antibiotic cocktails. After a
preliminary screening we focused on two of them
which were tested against a panel of bacterial species
commonly isolated from allograft tissues and com-
pared them to the antibiotic cocktail currently in use in
our facility at FBTV (cocktail Z). We did not include
any anti-mycotic drugs, since in our procedure the
presence of fungi in the pre-decontamination analysis
is an exclusion criterion for tissue. For the same reason
our bacterial panels did not include Streptococcus
pneumoniae, Streptococcus pyogenes, Serratia mar-
cescens, Meningococcus or Pseudomonas aeruginosa








24h 48h 24h 48h 24h 48h
 Achromobacter xilosoxidans 97.96 97.6 78.48 92.99 85.79 94.93
Acinetobacter baumannii 99.9 99.98 99.52 99.83 99.77 99.87
Aerococcus viridans 86.62 91.65 98.98 97.41 93.25 97.9
Aeromonas hydrophyla 99.77 NG 96.94 98.64 NG NG
Bacteroides 84.65 96.28 93.66 99.32 98.78 99.84
Corynebacterium striatum 93.36 93.52 94.77 98.79 98.57 99.86
Enterococcus faecalis ATCC29212 50.18 52.1 45.79 69.17 62.07 82.37
Enterococcus faecalis ATCC 51299 67.95 60.37 71.02 71 71.56 79.68
Escherichia coli NG NG 99.04 NG NG NG
Gemella morbillorum 88.18 87.55 93.79 96.855 94.59 93.78
Granulicatella adiacens 83.94 83.86 72.77 86.96 69.05 88.61
Haemophilus parainﬂuenzae 99.79 99.99 99.98 NG NG NG
Klebsiella pneumoniae ATCC700603 96.02 98.92 35.39 75.2 69.95 86.18
Klebsiellae pmenumoniae ATCC1706 98.59 99.67 99.5 99.7 99.44 99.88
Kocuria krisnae 92.88 96.02 99.89 98.4 99.97 99.83
Lactobacillus salivarius 59.874 78.8 94.275 96.51 96.04 97.23
Leuconostoc mesenteroides 57.57 54.17 80.155 85.86 92.23 95.16
Micrococcus luteus 99.945 98.97 91.12 90.04 83.43 86.26
Moraxella osloensis 99.265 99.76 NG NG NG NG
Peptostreptococcus anaerobius NG NG NG NG NG NG
Propionibacterium acnes 94.24 97.65 85.77 89.39 96.825 98.23
Proteus mirabilis AS10 73.15 76.58 68.72 77.64 69.42 82.51
Proteus mirabilis AS11 83.65 88.27 99.98 99.99 99.99 99.99
Sphingomonas paucimobilis 91.805 99.7 NG NG NG NG
Staphylococcus aureus AS12 (MRSA) 58.165 74.2 94.7 99.46 98.15 99.84
Staphylococcus aureus ATCC2913 (MSSA) 62.76 71.65 99.37 99.79 99.88 99.96
Staphylococcus epidermidis AS13 30.75 59.85 55.02 65.01 80.27 93.62
Staphylococcus epidermidis AS14 57.84 55.78 99.15 99.23 99.79 99.96
Staphylococcus hominis AS15 82.57 82.22 61.32 73.83 74.23 93.04
Staphylococcus hominis AS16 99.6 97.33 95.11 81.7 97.91 99.89
Staphylococcus hominis AS17 99.42 93.74 97.92 99.54 99.35 99.73
Streptococcus mis 70.75 72.61 92.49 96.26 99.98 NG
Streptococcus agalacae 89.75 86.84 95.83 89.8 98.39 99.47
Streptococcus salivarius 75.56 84.53 87.82 97.63 80.65 92.29
DCZ

















Fig. 2 Effect of incubation time on bactericidal activity at
4 C. The graph shows the number of strains killed at a tare
higher than 95 % after treatment for 24 and 48 h with different
antibiotic cocktails (Z, C and D)
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The efficacy of the cocktails was tested both at 4 C
for 24 or 48 h and at 22 C for 6 h. To prevent drug
carry-over interfering with the results, the bacteria
were rinsed in a drug-free medium before viability
counts. Two of the new cocktails (C and D) killed a
broad spectrum of bacteria even at 4 C and were
clearly more effective than cocktail Z. Specifically,
after incubation for 48 h at 4 C, 61 and 67 % of the
strains showed a kill rate higher than 95 % when
incubated with cocktail C or D, respectively, com-
pared to 44 % of the strains reaching the same kill rate
when incubated with cocktail Z. This effect was
probably due to the broader spectrum of action of the
antibiotics contained in the new cocktails compared to
cocktail Z (Table 2). Cocktails C and D, both
contained vancomycin and gentamicin, plus merope-
nem (cocktail C) or ciprofloxacin (cocktail D). The
superiority of cocktails C and D over cocktail Z mainly
lies in their increased bactericidal activity against
Streptococcus and Staphylococcus strains (Fig. 1),
which are the most commonly detected genera in
allografts. In particular, cocktail D showed a kill rate





















>95.00 90.00-94.99 80.00-89.99 <79.99
15 3 6 10
21 2 5 6
23 5 5 1
>95.00 90.00-94.99 80.00-89.99 <79.99
21 2 5 6
28 1 3 2
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Fig. 3 Effect of temperature on bactericidal activity. a Number of strains and different kill rates at 4 C for 48 h. b Number of strains
and different kill rates at 22 C for 6 h
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Treatment at a higher temperature (such as room
temperature, 22 C) for shorter times would increase
decontamination efficacy (in particular allowing
higher depletion of more resistant species including
Enterecoccus faecalis) and reduce processing times,
however this procedure might not be applicable to all
tissues due to their shorter survival at this temperature.
It would be interesting in the future to measure tissue
vitality at this temperature by performing specific
tests, and to assess the efficacy of short decontamina-
tion procedures using shorter incubation times.
It is important to point out that susceptibility
towards antibiotics varies within species, so the panel
of clinical and reference isolates used in this work
cannot cover all of the possible susceptibility spectra
of bacterial contaminants found in the field. One
drawback of our work was that our killing experiments
were performed in liquid medium, in different condi-
tions compared to those usually experienced by the
bacteria during allograft decontamination. To allevi-
ate this drawback, the medium was added with 0.5 %
foetal calf serum to increase the concentration of
proteins, which are obviously highly represented in
tissues and can bind with antibiotics.
With regard to the above mentioned issue, we will
shortly be analysing the microbiological results after
one year with the new cocktail to verify its efficacy in
allograft decontamination compared to cocktail Z.
Z C D
 Achromobacter xilosoxidans NG 99.48 98.83
Acinetobacter baumannii NG NG NG
Aerococcus viridans 94.81 99.99 99.93
Aeromonas hydrophyla NG NG NG
Bacteroides 81.125 82.06 97.51
Corynebacterium striatum 99.92 99.92 99.98
Enterococcus faecalis ATCC29212 74.95 99.61 69.01
Enterococcus faecalis ATCC 51299 44.45 86.32 62.91
Escherichia coli NG NG NG
Gemella morbillorum 99.92 99.91 99.83
Granulicatella adiacens 85 99.36 99.27
Haemophilus parainﬂuenzae NG 99.99 NG
Klebsiella pneumoniae ATCC700603 NG 99.92 99.55
Klebsiellae pmenumoniae ATCC1706 NG NG 99.99
Kocuria krisnae 97.15 99.98 99.98
Lactobacillus salivarius 83.35 99.99 99.98
Leuconostoc mesenteroides 59.23 99.98 99.99
Micrococcus luteus 99.98 98.12 97.5
Moraxella osloensis 99.83 NG NG
Peptostreptococcus anaerobius NG NG NG
Propionibacterium acnes 97.51 77.92 77.42
Proteus mirabilis AS10 99.84 99.81 65.83
Proteus mirabilis AS11 97.41 99.98 99.99
Sphingomonas paucimobilis NG NG NG
Staphylococcus aureus AS12 (MRSA) 85 99.98 99.97
Staphylococcus aureus ATCC2913 (MSSA) 94.36 99.99 99.98
Staphylococcus epidermidis AS13 71.11 77.3 98.79
Staphylococcus epidermidis AS14 96.66 NG NG
Staphylococcus hominis AS15 NG 81.34 76.83
Staphylococcus hominis AS16 NG 85.9 95.72
Staphylococcus hominis AS17 NG NG NG
Streptococcus mis 49.61 NG NG
Streptococcus agalacae 78.24 NG 99.93







Fig. 4 Bactericidal activity of antibiotic cocktails at 22 C. Data shown as % kill; NG no growth
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It is also worth noting that our experiments were
performed starting with cultures that had a bacterial
concentration of 105–106 cells/ml, a much higher load
than that found in allograft tissues, since a drug’s kill
rate is usually inversely proportional to the bacterial
load (i.e. inoculum effect; Udekwu et al. 2009); the
bactericidal activity shown in Figs. 1 and 4 might be
underestimated with respect to that obtained during
allograft decontamination.
In conclusion, in this work we characterized two
antibiotic formulations that displayed several advan-
tages validating our initial hypothesis that a cocktail
including gentamicin, ciprofloxacin or meropenem
would be more efficient than the one currently in use at
FBTV (cocktail Z): (1) both were found to be more
potent both at 4 and at 22 C; (2) both contained three
antibiotics instead of four, reducing the cost of
decontamination; and (3) both contained antibiotics
which are more readily available than lyncomicin and
polymyxin B (present in cocktail Z), as they are
commonly used in clinical practice. In addition, in
Italy polymixin B is no longer available as an
antibiotic for systemic use, but only for topical use
due to its toxicity.
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